sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Business Opportunities and Investment Strategies for Global Respiratory Drugs Market 2023-2033

Business Opportunities and Investment Strategies for Global Respiratory Drugs Market...

Home / Categories / Healthcare
Business Opportunities and Investment Strategies for Global Respiratory Drugs Market 2023-2033
Business Opportunities and Investment Strategies...
Report Code
RO1/105/1446

Publish Date
12/Jun/2024

Pages
189
PRICE
$ 1800/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 2350/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 2850/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
1 Introduction 10
1.1 Industry Definition and Research Scope 10
1.1.1 Industry Definition 10
1.1.2 Research Scope 11
1.2 Research Methodology 14
1.2.1 Overview of Market Research Methodology 14
1.2.2 Market Assumption 15
1.2.3 Secondary Data 15
1.2.4 Primary Data 15
1.2.5 Data Filtration and Model Design 16
1.2.6 Market Size/Share Estimation 17
1.2.7 Research Limitations 18
1.3 Executive Summary 19
2 Market Overview and Dynamics 22
2.1 Market Size and Forecast 22
2.1.1 Impact of COVID-19 on World Economy 23
2.1.2 Impact of COVID-19 on the Market 27
2.1.3 Impact of Russia-Ukraine Conflict 29
2.1.4 Impact of Israel-Palestine War 31
2.2 Major Growth Drivers 32
2.3 Market Restraints and Challenges 37
2.4 Emerging Opportunities and Market Trends 40
2.5 Porter's Fiver Forces Analysis 43
3 Segmentation of Global Market by Drug Type 47
3.1 Market Overview by Drug Type 47
3.2 Anti-Asthmatics & COPD Drugs 50
3.3 Cough & Cold Preparations 51
3.4 Pulmonary Hypertension Drugs 52
3.5 Idiopathic Pulmonary Fibrosis Drugs 53
3.6 Other Drug Types 54
4 Segmentation of Global Market by Disease 55
4.1 Market Overview by Disease 55
4.2 Asthma 58
4.3 COPD 59
4.4 Allergic Rhinitis 60
4.5 Cystic Fibrosis 61
4.6 Pulmonary Hypertension 62
4.7 Idiopathic Pulmonary Fibrosis 63
4.8 Other Respiratory Diseases 64
5 Segmentation of Global Market by Drug Composition 65
5.1 Market Overview by Drug Composition 65
5.2 Stand Alone Drugs 68
5.3 Combination Drugs 69
6 Segmentation of Global Market by Formulation 71
6.1 Market Overview by Formulation 71
6.2 Dry Powder 74
6.3 Tablets & Capsules 75
6.4 Sprays 76
6.5 Syrups & Solutions 77
7 Segmentation of Global Market by Administration 78
7.1 Market Overview by Administration 78
7.2 Inhalational Drugs 81
7.3 Oral Drugs 82
7.4 Injection Drugs 83
8 Segmentation of Global Market by Distribution Channel 84
8.1 Market Overview by Distribution Channel 84
8.2 Hospital Pharmacies 87
8.3 Retail Pharmacies 88
8.4 Online Pharmacies 89
9 Segmentation of Global Market by Region 90
9.1 Geographic Market Overview 2023-2033 90
9.2 North America Market 2023-2033 by Country 95
9.2.1 Overview of North America Market 95
9.2.2 U.S. 99
9.2.3 Canada 102
9.2.4 Mexico 104
9.3 European Market 2023-2033 by Country 106
9.3.1 Overview of European Market 106
9.3.2 Germany 110
9.3.3 U.K. 112
9.3.4 France 114
9.3.5 Spain 116
9.3.6 Italy 118
9.3.7 Russia 120
9.3.8 Rest of European Market 122
9.4 Asia-Pacific Market 2023-2033 by Country 124
9.4.1 Overview of Asia-Pacific Market 124
9.4.2 Japan 128
9.4.3 China 131
9.4.4 Australia 133
9.4.5 India 135
9.4.6 South Korea 137
9.4.7 Rest of APAC Region 139
9.5 South America Market 2023-2033 by Country 141
9.5.1 Argentina 145
9.5.2 Brazil 147
9.5.3 Chile 149
9.5.4 Rest of South America Market 151
9.6 MEA Market 2023-2033 by Country 152
9.6.1 UAE 156
9.6.2 Saudi Arabia 158
9.6.3 South Africa 160
9.6.4 Other National Markets 162
10 Competitive Landscape 163
10.1 Overview of Key Vendors 163
10.2 New Product Launch, Partnership, Investment, and M&A 166
10.3 Company Profiles 167
Abbott Laboratories 167
AstraZenca PLC 169
Boehringer Ingelheim GmbH 170
Bristol Myers Squibb Company 171
F. Hoffmann La Roche Ltd. 172
GlaxoSmithKline Plc 173
Merck & Co. Inc. 174
Novartis AG 175
Pfizer Inc. 176
Sanofi 177
Teva Pharmaceutical Industries Ltd. 178
Vertex Pharmaceuticals Inc. 179
11 Investing in Respiratory Drugs Industry: Risk Assessment and Management 180
11.1 Risk Evaluation of Global Market 180
11.2 Critical Success Factors (CSFs) 186
RELATED REPORTS 189

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com